The European Patent Office (EPO) has published patent application EP2024197126A1, which describes a novel technology involving grooved microneedles designed for both passive and active sampling of interstitial fluids. This publication indicates a new development in medical sampling technology, potentially impacting diagnostic and monitoring capabilities.

As this is a patent publication, there are no immediate compliance obligations for regulated entities. However, companies involved in medical device development, diagnostics, or pharmaceutical research should monitor this patent for potential future licensing or competitive implications. The application is designated for several European states, including Germany, France, and the United Kingdom.